1IQV Stock Overview

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. More details

1IQV fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	2/6
Financial Health	1/6
Dividends	0/6

Rewards

Trading at 45% below our estimate of its fair value

Earnings are forecast to grow 12.9% per year

Risk Analysis

Debt is not well covered by operating cash flow

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

IQVIA Holdings Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for IQVIA Holdings
Historical stock prices
Current Share Price	US$120.60
52 Week High	US$138.30
52 Week Low	US$125.30
Beta	1.35
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-7.97%

Recent updates

Shareholder Returns

	1IQV	IT Life Sciences	IT Market
7D	-3.0%	-0.8%	-0.2%
1Y	n/a	-5.4%	16.1%

Return vs Industry: Insufficient data to determine how 1IQV performed against the Italian Life Sciences industry.

Return vs Market: Insufficient data to determine how 1IQV performed against the Italian Market.

Price Volatility

Is 1IQV's price volatile compared to industry and market?
1IQV volatility
1IQV Average Weekly Movement	n/a
Life Sciences Industry Average Movement	7.2%
Market Average Movement	5.5%
10% most volatile stocks in IT Market	8.7%
10% least volatile stocks in IT Market	3.4%

Stable Share Price: 1IQV's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine 1IQV's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	89,000	Ari Bousbib	www.iqvia.com

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

IQVIA Holdings Inc. Fundamentals Summary

How do IQVIA Holdings's earnings and revenue compare to its market cap?
1IQV fundamental statistics
Market cap	€21.05b
Earnings (TTM)	€1.18b
Revenue (TTM)	€13.73b

17.9x

P/E Ratio

1.5x

P/S Ratio

Is 1IQV overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1IQV income statement (TTM)
Revenue	US$15.50b
Cost of Revenue	US$10.12b
Gross Profit	US$5.38b
Other Expenses	US$4.05b
Earnings	US$1.33b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	7.71
Gross Margin	34.72%
Net Profit Margin	8.61%
Debt/Equity Ratio	239.9%

How did 1IQV perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/22 10:35
End of Day Share Price	2025/05/22 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IQVIA Holdings Inc. is covered by 40 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jasper Hellweg	Argus Research Company
Gregory Bolan	Avondale Partners
Eric Coldwell	Baird

IQVIA Holdings BIT:1IQV Stock Report